ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note	Hit_Start	Hit_End	Antibiotic
BGC0000692.1|Apramycin_1 # 3 # 1199 # -1 # ID=1_1;partial=10;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.744	BGC0000692.1|Apramycin_1 	3	1199	-	Loose	680	25.409	LpeA	43.75	3004099	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGACGAGCACGGCGAGCGACCCGAACCGGGGCCCCGGCGGCCAGGCCGATCCCGGCTGGGTGATCGAGCGCACCGCCTACCGGCGGACCGAGGACAGCTTCTACGAGAGCCTGTTCGCCCTGTCCAACGGCCGGATCGGCGTCCGCGCGACCGCGGACTTCGACGCCGGAGGCGGTTGGCCCGGCTTCTACCACGCGCGGATGTACGCCAGGGCGGTGACCGTGCGGCGGCACCTGGTCAACGCGCCCACCCCGGCCTTCCGCGCCGTCCTGGTCGACGGCGTCCCGCTGGCGGTGACCGCGGACCGGGTGACGGAGTTCCGGCAGCGCCTCGACCTGCGCCGGGCCCGCCAGGAGCTGGTCGTCACCGTGCGCGACGGTCAGGGCCGGCACACCCGGATCGAGACGACCACCCTGCTGCCGGCGCAGTTCACCACCACCCTGGTCCAGCGCGTCGCGGTGACCCCGCTGGACCACGACGCCCCGGTCACGGTCCTGACCGGGGTGGACTGGTCGACCGGGAACGGCGACCTGGGCGGGCAGCTGCCCCGGGTCCGGGTGCACCACGCCGAACCGCTGGACCTGGGGTACCGCCCCGGCCGGCTGGACGCGCGGGTCCGCAGCTTCGGCCACGAGGAGGAGATCACCGAGCGGTTGGCGGTGCTGGCGGCGTCGGCCGAGCCGGAGGCACGGGACGTCTGCTTCGGCCGGGTCCGGCACGCCGAGGCGCTGCGCTTCGCCGGCGGGGCCGGGCGCGAGATCCGCGTGGACACCGTCGCCGTGATCAGCACGAACTTCGACGACGACGCTGTGTCCGTCGACCCCGACGTGGACGCGGTGCCCGACATCGACCTGGTGGTGGCCGAGCACGAGCGGATCTGGGCCGAGCGCTGGCGGCGGCACGCCGAGGTCGAGGGCGACCCGGCGATCGTGCAGGGCATGCGGTACTCGCAGTTCCACCTGTTCGGGTCGATCGACCGCGGCCGGACCGTCCACAACGTCCCGGCCAGGGGGCTGAGCAGCGAGTACCACTCGGGGCACTTCTTCTACAACACGGAGTTCTTCGCGCTGCCGCACGCCGCGTGGACCGATCCGGCGGCGGCCAAGGCCATGCTGCGGTTCCGCGTCGCCACGCTGGACGCGGCGCGCGAGCACGCGCGGCGCACCGGCTACGAGGGCGCCCGCTTCCCGGAGGAG	MTSTASDPNRGPGGQADPGWVIERTAYRRTEDSFYESLFALSNGRIGVRATADFDAGGGWPGFYHARMYARAVTVRRHLVNAPTPAFRAVLVDGVPLAVTADRVTEFRQRLDLRRARQELVVTVRDGQGRHTRIETTTLLPAQFTTTLVQRVAVTPLDHDAPVTVLTGVDWSTGNGDLGGQLPRVRVHHAEPLDLGYRPGRLDARVRSFGHEEEITERLAVLAASAEPEARDVCFGRVRHAEALRFAGGAGREIRVDTVAVISTNFDDDAVSVDPDVDAVPDIDLVVAEHERIWAERWRRHAEVEGDPAIVQGMRYSQFHLFGSIDRGRTVHNVPARGLSSEYHSGHFFYNTEFFALPHAAWTDPAAAKAMLRFRVATLDAAREHARRTGYEGARFPEE	MLGIQFNRGQWRSNYYWQIPVLIIAVISILFFISKKLFYSKVTPESIPNKLVEVEPIKSHNLQQTIHLLGTIHPKHATTLIAKESGMLDTLIPTGQKVTKGTLIAKINNPDLEKNLQLSLSAVELAKAQYERITPLIKSGYVSTKEVEEKKQAWIDAQKELSKTRIELDNLRFYAPFDGIIGAYKKREGAQVNAGESVVSIYDPSALVVDFDIPCSNLATLNEGQPVYVLGKRYSLSHLQKMLDEDTHMCPADVDIQCDDCLIGATTSVELLVAEKNNTIVIPFQAIFLRNSKPFVYLVKKGKIVLASVKTGLQQEDKIEIVEGLKAGQQLVTKGQERLYPEMTVDIYHPATSSS	112.39	gnl|BL_ORD_ID|2386|hsp_num:0	2758			666	756	erythromycin; spiramycin; azithromycin
BGC0000692.1|Apramycin_2 # 1196 # 2134 # -1 # ID=1_2;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=6bp;gc_cont=0.774	BGC0000692.1|Apramycin_2 	1196	2134	-	Loose	1200	31.5722	arnA	28.03	3002985	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	pmr phosphoethanolamine transferase	ATGCGCATCTTCGTGACCGGGGCCGCCGGTTACGTCGGCCAGGCGGTCCTCGCGCGGCTGCTCGCCGCCGGGCACGACGTCACGGCCGTCGGCCACCGGACTCCGGTCGGGTGGCCGGCGGGCACGCCGAGCCGCCAGGCCGACCTGACCGACGCCCCGGCGGTGCTCCGGGCGCTCGACGGCGCCGAGGCGGTCTGCCACCTCGCCGGGCTGACCAGGGTGCGGGGAAGCGGCGTGGACGTGGACCGGTACTACCGGGTCAACGTGGTGGGCACCCTCAACGTGCTGGACGCCCTGGTCGCCCGGCACCGGGCCGGGGACGGCCCGGCCCGGCTGGTGTTCCTGTCCAGCGGGGCGGTCTACGGGCGGACCGGCGACGCGCCGGTCCGCGAGGACCACCCGACGCTGCCGACCAGCGCGTACGGGGCCACGAAGCTCGCGGCGGAGCAGGCCGTCGGCTGGTACGCGGGGACCGGCGCGCTGTCGGCGGTCTCGCTGCGCCTGTTCACCGCGGCGGGCAGCGTCCGCCCCGGTTGTCGGCCGGACGACAGCACCCTCGTCGCGCGGGCGCTGTCCGTCGCGGCGGGAGAGAACGCTGTTCTCCCGGTCAACGGCGACGGCTCGACGGTGCGGGACTTCGTGCACGTCGCCGACGTCGCCGACGCGGTCGCCCGCGCGGTCGAAGCGCCGGCGCGCCGGCCGGCCGAGGTGGTCAACCTGGGCGCCGTCGCGGCGAGCGTGCGCGAGGTGGTCGCGGCGGTCGAACGCGTCACCGGCCGCCGCGTCCCGGTGGCGCACGGCCCGGCGAACAGCGCGGACCAGCCGTGGCTGGCGGCCGACACCGGCGCGGCCAGGGAGCTGCTCGGCTGGGCGCCGACCCGGTCGAGCCTGGAACGGATGATCGAGGACCAGTGGCGAGTCGGGGGAGCGGGACGATGA	MRIFVTGAAGYVGQAVLARLLAAGHDVTAVGHRTPVGWPAGTPSRQADLTDAPAVLRALDGAEAVCHLAGLTRVRGSGVDVDRYYRVNVVGTLNVLDALVARHRAGDGPARLVFLSSGAVYGRTGDAPVREDHPTLPTSAYGATKLAAEQAVGWYAGTGALSAVSLRLFTAAGSVRPGCRPDDSTLVARALSVAAGENAVLPVNGDGSTVRDFVHVADVADAVARAVEAPARRPAEVVNLGAVAASVREVVAAVERVTGRRVPVAHGPANSADQPWLAADTGAARELLGWAPTRSSLERMIEDQWRVGGAGR	MTSKAVVFAYHDIGCTGIEALLNAGYEIAAVFTHADDPRENTFYASVARLCAERGIPLHAPEDVNHPLWLERIRQLRPDFLFSFYYRRLLGAELLACAARGAYNLHGSLLPRYRGRAPANWVLVNGETQTGVTLHRMIERADAGPILAQQAVAIDPEDTALSLHGKLRKAAGALLRDSLPLLALGVLPEVEQDESQASHFGRRTPADGLLDWHRPARQLYDLVRAVTQPYPGAFCQVGEQKLIVWSAEVVAGNHGREPGSVLSCDPLRIACGEDSLVLRFGQRGERGLYLAGTQLATELGLVEGARLRGAACSPQRRTRVLILGVNGFIGNHLSERLLRDGRYEVHGMDIGSDAIERLKADPHFHFVEGDIGIHSEWLEYHVKKCDVILPLVAIATPIEYTRNPLRVFELDFEENLRIVRYCVKYGKRVVFPSTSEVYGMCQDPDFDEDRSNLVVGPINKQRWIYSVSKQLLDRVIWAYGQQGLRFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILHLVEGTPIRLVDGGAQKRCFTDVDDGIEALARIIDNRDGRCDGQIVNIGNPDNEASIRQLGEELLRQFEAHPLRAQFPPFAGFREVESRSFYGDGYQDVAHRKPSIDNARRLLDWQPTIELRETIGKTLDFFLHEALREREAQA	47.13	gnl|BL_ORD_ID|1513|hsp_num:0	1643			1281	1734	polymyxin B
BGC0000692.1|Apramycin_3 # 2150 # 3448 # -1 # ID=1_3;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.761	BGC0000692.1|Apramycin_3 	2150	3448	-	Loose	400	38.891	QnrVC1	22.31	3002799	protein homolog model	n/a	n/a	fluoroquinolone antibiotic	antibiotic target protection	quinolone resistance protein (qnr)	GTGGGCGGGGGCGGGGGCGCGGTGACCGCCGCCGCGACCGGCGTCTGGGGCTGGGCCGGCGAGCTGGACGGGCAGCCCCCGGACGAGACGCTCGCCGAGGTCGCCGCCCGCGCGCCGGCGTCCCCGGCGGAGCTCCTCACGACGCGCCTGCCGCCGGGCGGGCTGCTGGTGGTCACCGCGCGGCACGGCCGCCGACGCCCGGACGCCGGGCTGTTGACGCGCCTGACCGCGTCGGGGCTCACTACGGAGATCCTTCGGTTGGCCGGCGCGGAGATGGGCTCGACCGACGCGTTCGCGTCCACTGTGGACAATGATCCGCACCCCGACGTCCTGGTGCTGGACGCCCCGGACCTGGCGGCATGGGGCGGGCGCGGGGTCGACGGGCTGGTGCTGCGGAACCTCCTGGAGCGCCTGCGCTCCCGGCTGCCGAACACCCGGCTGGCGATCTACGTCAGCGACGCCTGCTTCGTGGTCCGGCACGCGTTGCCGGGCACGTTGCTGCTCACCCTGCCCCGCCAGGACGAGGACGACCCGGCGACCGGCCCGCTGGCCGACCGCGCCGAGGAGGTCGCGGCCGCTCTCGGGACCGGCGACGCCCGGGCGGTCGTCGAGGCGTGCGACGCCCTCGCGCGGCGGCCGGAGTTCGACCCGATGAGTCCGGCGCGCCGCCTGCTCGACGCGGTCGCGGGACACCCGGACGCGCTGCGCGAGATCGTGCCGGAGTTGTTGGCCCGCCACTGGCCGGCCGCTCCCACCACGTCGCCGCTGGAGGACGGTGGAGTGTCGCCCCGGGCGACGGCGTTGCTCTACCGCCTGCTCTCGCTGACCGAGCCGGACGGACCTCGGTCCACCCTCCGCCGCGTCGACGTCGGGCGGTGGCTGTGCGCCCTGCGCGCGGACACCTACGAGACCCTCAGCGCGGTGACCACGGTGCTGCGGCACGAGGACCTCGCCGGGACCAACCTCTCGTACGCGCCGTCGCTGGAGCACTGCGACCTGACCGGCGCCGACCTCACCGAGGTCGACGGCTACCGGGTCAACGTCTCGGACGGCGTGCTGGACAACGCGCTGATGGCCCGGTCCTGCTTCGCGCGCGGCCACCTGAAACGCGCCTCCCTGCGGGGCGCGGACCTCAGGGACGCCGACCTGGAGTACGCCTCGTTCCAGCAGGCGGACCTCACCGGCGCCGACCTCGCCGGGGCCGACCTGCACCGCGCGTTGCTGGACCAGGCGGTCGGGCTGTCCGTGCCGGTCCCAGCACCGGTCCCGGCGCCGGCGATCGAGCCCACGTCTGCCTAG	MGGGGGAVTAAATGVWGWAGELDGQPPDETLAEVAARAPASPAELLTTRLPPGGLLVVTARHGRRRPDAGLLTRLTASGLTTEILRLAGAEMGSTDAFASTVDNDPHPDVLVLDAPDLAAWGGRGVDGLVLRNLLERLRSRLPNTRLAIYVSDACFVVRHALPGTLLLTLPRQDEDDPATGPLADRAEEVAAALGTGDARAVVEACDALARRPEFDPMSPARRLLDAVAGHPDALREIVPELLARHWPAAPTTSPLEDGGVSPRATALLYRLLSLTEPDGPRSTLRRVDVGRWLCALRADTYETLSAVTTVLRHEDLAGTNLSYAPSLEHCDLTGADLTEVDGYRVNVSDGVLDNALMARSCFARGHLKRASLRGADLRDADLEYASFQQADLTGADLAGADLHRALLDQAVGLSVPVPAPVPAPAIEPTSA	MEKSKQLYNQVNFSHQDLQEHIFSNCTFIHCNFKRSNLRDTQFINCTFIEQGALEGCDFSYADLRDASFKNCQLSMSHFKGANCFGIELRDCDLKGANFSQVSFVNQVSNKMYFCSAYITGCNLSYANFEQQLIEKCDLFENRWIGANLRGASFKESDLSRGVFSEDCWEQFRVQGCDLSHSELYGLDPRKIDLTGVKICSWQQEQLLEQLGVIIVPD	198.17	gnl|BL_ORD_ID|1239|hsp_num:0	1351			51	411	ciprofloxacin; levofloxacin; moxifloxacin; gatifloxacin; nalidixic acid; norfloxacin; sparfloxacin
BGC0000692.1|Apramycin_4 # 3424 # 4449 # -1 # ID=1_4;partial=00;start_type=TTG;rbs_motif=AGG;rbs_spacer=8bp;gc_cont=0.700	BGC0000692.1|Apramycin_4 	3424	4449	-	Loose	500	29.261	OXA-662	26.58	3005877	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	TTGAGCGGAAACAGCCCCCAGGAGCTGAAGAGCGCGGCTCAGCGAGCGGCGAACTGGCTGGTGGAGCGGCAGCGCCCGAACGGCGCGCTGCCCTCCAGGACCGCCGTCATCGAGTCCTGCTACAAGGGGATGTGGGCGCTGCACACCGCCGGCCACACCCAGGCCGCGAGCGCGGTCGCGGACTACGTGACGTCGCTGCTCCAGGCCGACGGCGACATCCCGCAGCCGCGCGAGGAGGAGTACTTCCTCGACGTCCACTACCTCTACGCCAACGGCTACCTGACCATCGGCGCGCACGTGCTCGGCCGGTTCGGCCTCTCCTCGAAGCTGATGTCCTTCGTCGAGACCATGCAGAACCCGGTGACCGGCGGTTTCCGCTCCCACGGGCCGGCCGTGCCCGGCGACGGCCGGTGCGACTCGGTCTCGACCAGCATCAGCGGTCTCGCCGCGCTCTACACCGGCCGGCTGTCGGTCGCCAGGTCCGCCGCCGACTTCCTCGGCTCGCTGTGGGCCGGGCAGCCGGACAGGGAGAACCTGTTCCACGCCGTGGCCGACGCGCAGGGCAACGTGCTGACCAGCGACGACGCCGTCACGATCTCGGTGAGGAAGGCCGAGGGCGACTGGTACTTCATCGGTCTGCCCGCGCTCTTCCTGACCGCGCTGCACGAGGCCACCGAGGACCAGAAGTACCTCGACCTGGCCACCGAGCTGATGACCTACATGGACGAGACCTGTGACGACGACGCGTTCATCGACTCCTCGTGCGGCAAGGCCGGGGTCGCCGCGGCGATGCTCTACCGCCTGACCGGGAAGCCCCGGTACCGCGAGATCGCGCAGCAGATCGGCGACCTGCTGTGCGAGCGGCAGACCCCGTACGGCTACTGGTCCGAGGAGGAGACCGACGACGTGGCCGACCTGTTCTGGGGCGACCTGGACATGACGGCCGAGTACGTGATGTGGCTCGACCTGATCGCGCGGAACCTGGCCAGCGGCGAGCGGGTGTGGGCGGGGGCGGGGGCGCGGTGA	MSGNSPQELKSAAQRAANWLVERQRPNGALPSRTAVIESCYKGMWALHTAGHTQAASAVADYVTSLLQADGDIPQPREEEYFLDVHYLYANGYLTIGAHVLGRFGLSSKLMSFVETMQNPVTGGFRSHGPAVPGDGRCDSVSTSISGLAALYTGRLSVARSAADFLGSLWAGQPDRENLFHAVADAQGNVLTSDDAVTISVRKAEGDWYFIGLPALFLTALHEATEDQKYLDLATELMTYMDETCDDDAFIDSSCGKAGVAAAMLYRLTGKPRYREIAQQIGDLLCERQTPYGYWSEEETDDVADLFWGDLDMTAEYVMWLDLIARNLASGERVWAGAGAR	MKTLQFGFIALITTFSSACTTISPSVETAKNQQQQSAQQQIQQAFDQLQTTGVIVIKDKHGLHSYGNDLSRAQTPYVPASTFKMLNALIGLEHGKATSTEVFKWDGQKRSFPAWEKDMTLGQAMQASAVPVYQELARRIGLDLMQKEVQRIRYGNQQIGTVVDNFWLVGPLQITPVQEVLFVEKLANTQLAFKPDVQHAVQDLLLIEQKPNYKLYAKSGWGMDLEPQVGWWTGWVETATGEKVYFALNMHMKTGISASVREQLVKQSLTALGII	124.45	gnl|BL_ORD_ID|3912|hsp_num:0	4982			348	564	cloxacillin; oxacillin; cefalotin
BGC0000692.1|Apramycin_5 # 4471 # 5055 # 1 # ID=1_5;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.715	BGC0000692.1|Apramycin_5 	4471	5055	+	Loose	500	27.335	bacA	38.71	3002986	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	undecaprenyl pyrophosphate related proteins	ATGGATGGGCGATTCTGGAAGAAACCCGCTCGGGTCTCGCGCCGACCGCCGCCGCGGCCGGAGAGGGGCGGGAGCCGCGACGACCGCGGGACCGACGTGCCGGCAATGGCGCACCCGATCGGCGTGGACATCCCGGGAAGCGGGGTCCGGACGATTCCGCGAGCGGGAACCGCGAACCGGGACCGCGTTTCGCCGGGAGCCGAAGAATCAGGTCGGCGGGACGGGTGCGCGCATGACGGCGAATCCGGCCGACGAGCTTCCGGAGCGAACGACATCGACCACGGGCGTCGGGTGGACCACGGCGCGCCGCTCGGGGCCGGCCGACGGGACAACCCACTGGACAGGCCGTACGGCCTGCTGGTTCGGCGATGCCGGAACCCGCGCGAGCCGCGGATGCCCGGGAAACCGGGCGGCGTTTCGGGACGGGACGCCGTCCACGCGACCGTTCGTGACCAAGAGGTGGCCGCCCCCTCCCAGCTTCCCGCCACGTGCGACCGGGAAATCGGCATGGATCGTCAACAGCCTGTTCGGGTGCCGAGGATCGCACGCGTTCACGACGCGTCGAAATACGCCGAACGAGGGTAA	MDGRFWKKPARVSRRPPPRPERGGSRDDRGTDVPAMAHPIGVDIPGSGVRTIPRAGTANRDRVSPGAEESGRRDGCAHDGESGRRASGANDIDHGRRVDHGAPLGAGRRDNPLDRPYGLLVRRCRNPREPRMPGKPGGVSGRDAVHATVRDQEVAAPSQLPATCDREIGMDRQQPVRVPRIARVHDASKYAERG	MSDMHSLLIAAILGVVEGLTEFLPVSSTGHMIIVGHLLGFEGDTAKTFEVVIQLGSILAVVVMFWRRLFGLIGIHFGRPLQHEGESKGRLTLIHILLGMIPAVVLGLLFHDTIKSLFNPINVMYALVVGGLLLIAAECLKPKEPRAPGLDDMTYRQAFMIGCFQCLALWPGFSRSGATISGGMLMGVSRYAASEFSFLLAVPMMMGATALDLYKSWGFLTSGDIPMFAVGFITAFVVALIAIKTFLQLIKRISFIPFAIYRFIVAAAVYVVFF	71.06	gnl|BL_ORD_ID|1681|hsp_num:0	1820			351	444	bacitracin; bacitracin A; bacitracin B; bacitracin F
BGC0000692.1|Apramycin_7 # 5261 # 6337 # 1 # ID=1_7;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=4bp;gc_cont=0.794	BGC0000692.1|Apramycin_7 	5261	6337	+	Loose	700	28.8758	vanS gene in vanL cluster	34.04	3002938	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	vanS; glycopeptide resistance gene cluster	ATGAGAATTGACGACGTCACGCGCCCCGGCCTCGCCGGCGGTGTCGTCGCGCTGCGGGCCGACGCCTCCGCGGAGTGGGGGGTGGGGCACGTCGTCCGCTGCCTCGCCCTCGCCGAGGAGGTCCTGGCCAGGGGCGGCCGGCCGGTGCTCGTCGCCGACCTCGGCGACGTGGCCTGGCTGGCGGAGGAGGTCCGGGCGCGCGGGCTCGCGGTGCGCCCTCCGGCGAGCGACCCGGCGGGGTTCGCCGACCAGCTCCACGCGCTCGGCGCGCGCGCCACGGTGATCGACTCCTACCGGCTCGGCCCCGAGCACTACACGGCGGCGCGCGCGGTCGCGCCGGTCGTCGCGCTCTACGACCGCCACTCCGGGCCGGTCCCCGGCGACGTGCTGGTCGACCAGGTCTTCGGCGCGGAACAGGACCCGCCGCCACCGGACGCCGACCAGGCGACGGTGCTGCGCGGACCTCGGTACGCGCTCATCCGGGACCTCGTCCGGCGTCACCGGCCAGCCACCCGACCCGCGGCCATGCCCCTCGCCGGGCGGGCGCCCCGGGTGCTGCTGGTGCTGGGCGGCACCGACGCCCGCGGCGCGACCGGGGCCCTCACCGAGATCCTGCTGGCGTCCTGCCCGTCGCTCGACCTCACCGTGGTCGGCGGCGGCCTCGACGGCCCCGCGCCGGCCACCGGCGCCGGCCAGCGCCTGTCGGTCCACCGACCGTCGGCCGAGCTGCCCCGGCTGATGGCCGAGGCCGACCTGGTGATCAGCGCGGCCGGCACCACGTTGGCGGAGCTCTGCTGCGTGGGCGCGGCGGCCGCCGCCGTGTGGGTGGTGGACAACCAGCTTCCCGTCTACCGCAGCGCGCTCGCCGCCGGCTGCGTGCACGGACTGGGCTCGCTCGCGGAGGTGCTGGCCGACCCCGGGCGCGCCGGCGCGGCCGTCCGCGCGCTGCTGGAGTCGCCGGAGCGCCGGACCGCGCTGGCCGGCGCGGCGTGGGAGCTGGTGGACGGCGCGGGCCGCGGCCGGGTGGTCGACGCTCTGGCGGCCCGGCTCGCCGACCGCCGGCCCGCCACCCGCTGA	MRIDDVTRPGLAGGVVALRADASAEWGVGHVVRCLALAEEVLARGGRPVLVADLGDVAWLAEEVRARGLAVRPPASDPAGFADQLHALGARATVIDSYRLGPEHYTAARAVAPVVALYDRHSGPVPGDVLVDQVFGAEQDPPPPDADQATVLRGPRYALIRDLVRRHRPATRPAAMPLAGRAPRVLLVLGGTDARGATGALTEILLASCPSLDLTVVGGGLDGPAPATGAGQRLSVHRPSAELPRLMAEADLVISAAGTTLAELCCVGAAAAAVWVVDNQLPVYRSALAAGCVHGLGSLAEVLADPGRAGAAVRALLESPERRTALAGAAWELVDGAGRGRVVDALAARLADRRPATR	MKSKAETTTIKQILIKYLVTIGLSMLAYLVFLLTILIIMRNFVWDGTEPIYRVLHFFYRLFNFEGILIIGVILILFVVTLFFVMKIIGYLKQIIEATKQLLEKPEQRVKLSSGLFELQEEMNQLREKNNADNRAAKEAEKRKNDLIVYLAHDLRTPLTSVIGYLTLLKEEPEISVQTRAKYTNIALSKAFRLEELLSEFFDVTRFNLTNLTINEELVDLSVMLEQISYEFLPILEEKKLSWNLHVESNIKSLLDPGKMERVFDNLMRNAINYSFEDTIIDLSLEKKESQAIFKITNRTYTIPKEKLEKIFEPFYRMDTSRSSSTGGTGLGLPIVREIIEASKGTINVSSSNNEMTFIIYLPYID	98.35	gnl|BL_ORD_ID|4734|hsp_num:0	744			285	426	vancomycin
BGC0000692.1|Apramycin_8 # 6425 # 7213 # 1 # ID=1_8;partial=00;start_type=GTG;rbs_motif=AGG;rbs_spacer=9bp;gc_cont=0.754	BGC0000692.1|Apramycin_8 	6425	7213	+	Loose	300	25.409	AAC(3)-IIb	42.86	3002534	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	AAC(3)	GTGCCCAGGATCGACGAGTCCCGCCTGCGTGATCTCCTCGCCGCCGCCGCCGGGGTGGCGCCGGCCGAGCTGGACGGCTGGCCCGGCCGGGCCGGCTGGCTGGACCGGGCGGCCGCGATGCTCACCGACTACGTGGCCGGCGTGCCGCTCGGGTACGTGCTCGGGGAGATCCACTACCTGGGCAGGGCGTTCCGCAGCGACCGCCGCGCCCTGGCCGTCCGCCGGTACAGCGAGCCGCTGGTGCGGCGGATCGTCGACGACTTCGCCGGCGAGCCGGTGCGCGCGGTGGAGATCGGCTGCGGGGCCGCCGCCGCCATCTGCACCCTCGCCAAGGAGCTGACCGGCGAGTTCGTCGGGACCGACGTCGTACCGGAGGCGCTGGAGCTGGCCGAGGAGAACGCGACCCGGCACCGGGCCCCGGTCCGGTTCGTCGTGAGCGACCTGTTCGACGCGCTCGACGGCCGGTTCGACGTGATCTACGCGAACCTGCCCCGCCACCACCCGAGCACGCCCATGCCGGAGGCCCGGTGGGAGCCCTCCGTCGCGCTGTACGACGACAGCGCCGAGCCGTTCGGGCTGCTCCGGCGGTTCTTCGCCGAGGTGCCGGACCGGCTGACCGAGCGGGGCCGGCTGTACCTGGAGATCCCGCTGGACCCCGCGATCGCGGACCTGCTGCCGGGTGAGCCGGTGGTAGACGGCGACGGGGACGACTTCGCCCGGGTGATCACCGCGGCCGACGCCCGCCGGCTCCCGGCGCTGGTCGACCGGCTCACCTGGCCCGAGGGGTGA	MPRIDESRLRDLLAAAAGVAPAELDGWPGRAGWLDRAAAMLTDYVAGVPLGYVLGEIHYLGRAFRSDRRALAVRRYSEPLVRRIVDDFAGEPVRAVEIGCGAAAAICTLAKELTGEFVGTDVVPEALELAEENATRHRAPVRFVVSDLFDALDGRFDVIYANLPRHHPSTPMPEARWEPSVALYDDSAEPFGLLRRFFAEVPDRLTERGRLYLEIPLDPAIADLLPGEPVVDGDGDDFARVITAADARRLPALVDRLTWPEG	MNTIESITADLHGLGVRPGDLIMVHASLKAVGPVEGGAASVVSALRAAVGSAGTLMGYASWDRSPYEETLNGARMDEELRRRWPPFDLATSGTYPGFGLLNRFLLEAPDARRSAHPDASMVAVGPLAATLTEPHRLGQALGEGSPLERFVGHGGKVLLLGAPLDSVTVLHYAEAIAPIPNKRRVTYEMPMLGPDGRVRWELAEDFDSNGILDCFAVDGKPDAVETIAKAYVELGRHREGIVGRAPSYLFEAQDIVSFGVTYLEQHFGAP	97.40	gnl|BL_ORD_ID|850|hsp_num:0	925			243	327	dibekacin; sisomicin; netilmicin; tobramycin; 6'-N-ethylnetilmicin; 2'-N-ethylnetilmicin; gentamicin
BGC0000692.1|Apramycin_9 # 7322 # 8035 # -1 # ID=1_9;partial=00;start_type=GTG;rbs_motif=AGG;rbs_spacer=6bp;gc_cont=0.762	BGC0000692.1|Apramycin_9 	7322	8035	-	Loose	300	25.7942	dfrA13	55.56	3003012	protein homolog model	n/a	n/a	diaminopyrimidine antibiotic	antibiotic target replacement	trimethoprim resistant dihydrofolate reductase dfr	GTGCGCGACACCGAGAACGCGGCGCTGGTCGTCCTCGACATCGACGGCACGCTGCTGGACACGCCCCACCTGCCGGCATGGCGCCGGGGCCTGGCCAGGGTGCTGCGCGACCACGCGCCGGAGCGCTCCGCCGAGATCACGGTGGAGCGGTACCACCGGCACATCGCGGGCCGGCCGAGGCAGGTCGGGGCCAGGGCCGCGCTGGAGCTCGCCGGGCTGGCGCCCCCGCCGGCGCTGGTCGACGAGCTGGCCGCGGTCAAGCAGCAGGTGTTCCTGGAGCAGGCCGAGGAGACCGTCCTGTTCCCCGACGCCGGGGACTTCCTCGACGCGGCGGCGCTGGCGGGCACGCCGCTGGCGTTCTGCACGGCCTCCCGCAACGCCGGCGAGCTGCTGGCCAAGCGCCTTCCCCGACTCGACGGCGGCGACTGGCTGCTCGACCGGCTGCACCACAGCCTCGGCCCGCACGGCCACTACGGCGACGTCCCCCGGCCGGAGGCGCTGCGTCGCGTGGCGGCGGCGTGGGGCGCCGCGCCCGACGGCTGCGTGCTGGTGGACGACGCCCTGTCCGGCGTTCTCGCCGGACAACAGGTCGGGATGACCGCGGTCCTGGTCGACCGGTTCGGGCTGGGCGTCGCCGCGCCCGGCTGCCCCACCGTGAGCACGTTGGCCGAACTGGTCCCGGTGTCGACCGGTGTGCGGTTTCCGGCCGAGTAG	MRDTENAALVVLDIDGTLLDTPHLPAWRRGLARVLRDHAPERSAEITVERYHRHIAGRPRQVGARAALELAGLAPPPALVDELAAVKQQVFLEQAEETVLFPDAGDFLDAAALAGTPLAFCTASRNAGELLAKRLPRLDGGDWLLDRLHHSLGPHGHYGDVPRPEALRRVAAAWGAAPDGCVLVDDALSGVLAGQQVGMTAVLVDRFGLGVAAPGCPTVSTLAELVPVSTGVRFPAE	MNPESVRIYLVAAMGANRVIGNGPDIPWKIPGEQKIFRRLTESKVVVMGRKTFESIGKPLPNRHTVVLSRQAGYSAPGCAVVSTLSHVSPSTAEHGKELYVARGAEVYALALPHANGVFLSEVHQTFEGDAFFPVLNAAEFEVVSSETIQGTITYTHSVYARRNG	143.64	gnl|BL_ORD_ID|97|hsp_num:0	114			216	270	trimethoprim
BGC0000692.1|Apramycin_10 # 8039 # 8503 # -1 # ID=1_10;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=8bp;gc_cont=0.710	BGC0000692.1|Apramycin_10 	8039	8503	-	Loose	750	27.7202	tet(53)	30.77	3004589	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic inactivation	tetracycline inactivation enzyme	ATGCCGGCAGCGCAGGACCTGCGCGAACAGCTCGCCCGGCAGAAGATCACGCTCGGCGTGTGCCACGGGTGCTTCGACATCCTCCACAGCGGACACGTCCACCACCTGACCCAGGCGGCGGGGCACACCGACCGGCTCCTGGTCTCGGTCACCGCGGCCCGGCGCATCAACAAGGGCCCCAACCGGCCGGTCTTCGACGACGAGGCCCGGCTGACCGTGCTGGCCGCGCTGGAGGTCGTCGACTACGTGCTGCTCAACGACGACGACACCGCGGTCCCGCTGATCCGCGCGTTGCGGCCCGACTACTACTTCAAGGGCGCCGACTACGCGAACATGCGGGACCCGCGGGTGGTCGAGGAGGTCGACGCGGTCAGCGCCGTCGGCGGGAGCTTCGTGCTGACCGACGACGCCGTGTTCGACTCCTCGACCCGCGCCGCCGGCCTGCTCCTCGACTCGGGGAGGTAG	MPAAQDLREQLARQKITLGVCHGCFDILHSGHVHHLTQAAGHTDRLLVSVTAARRINKGPNRPVFDDEARLTVLAALEVVDYVLLNDDDTAVPLIRALRPDYYFKGADYANMRDPRVVEEVDAVSAVGGSFVLTDDAVFDSSTRAAGLLLDSGR	MSTINKILVIGAGIAGPAVCYWLRRFGFSPVLIEKFANIRKEGQALDFRGVAIDIVKGMNIYEKMCNMHKQLEVGRYVDTEGNTLHEERGERFCFRQGEDVEIARGDFAEILTGAIEGIPCHFNQVIDSIKQSDDDVKVQFNDGRVEHYDLVIGADGIYSTTRGMVFDKDEYKLVNLGVCFGVFSILNYLNLSHTEVQCEANQKLISIWSHKNPKMAEVAFVFRTQNVLNNIRNKNEQQQLLRDAFQDFGWEASKILELMTGSDDFYFDSATQVKMKSWTKGRVALLGDAGYSASPLSGQGNYLALVGAYIFAGELKKADGNYTRAFSRYNELLHPLVEACHKLGVLVSESFLVPDEVSKEVAEERSNKILQEVKIVSNMISLPEYE	39.79	gnl|BL_ORD_ID|2724|hsp_num:0	3290			522	636	tetracycline; minocycline; oxytetracycline
BGC0000692.1|Apramycin_11 # 8588 # 9997 # -1 # ID=1_11;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=8bp;gc_cont=0.774	BGC0000692.1|Apramycin_11 	8588	9997	-	Loose	700	55.4546	LpsB	27.94	3005051	protein homolog model	n/a	n/a	peptide antibiotic	reduced permeability to antibiotic	Intrinsic peptide antibiotic resistant Lps	ATGCGGTTGCGCGTGCTGCGGCTCACCCCGTTCTTCCACCACGACTGCGTGGACCGGTGGCCGGCGGAGTTCGACGCCGTCGGCGGGATGCAGGTGCAGATCCTCCGGCTGTCGCGGCAACTGGCGCGGCGCGGCGTGCGGCAGGAGGTGCTCACGGTCGGGTTCCCCGGCCTGCCCCGGGTCCGGGAGGACTCGCCGGGGCTGGTCGTCCGGATCACCAGGGCCCCGATGCCCCGGCTGCGGTCGGAGCTGACCGGGTTGGTCGGCCTGAACCTGGCGTGGTTCCTCGGCGCGATGGCCGAGTGCGCGCGCCGGCGGCGGAGCCGGCGGCCGGACCTCATCCAGGTGCACGCCGACGGCCAGCTCTGGGCGCTGCTGGCCGGGCCGATCGCCTCGGCCCTGCTGCGGCGGCCCTACAGCCTGGTGCTGCACTGCTCGCGGCTGGGCGTCTACCAGCCGATGTCCCGGTACGACCAGTGGCAGCACCGGTTCGTCGCCGCGGTCGAGCGGTGGGCGCTGCGGCGGGCGGACGGGGTGTGCGCCCTGACCGCACGCACGGCCGACGTCGTCCGGGCGGCGCTGCGCCCGCACGCCGTGCGCGTCGACGTGGTGCCCGACTCGGTGGACCCGGAACCCCCGGTGGACGCGGGGGTTCCGGTGGCTGAGCGGCTGCGCGCCGCCGGGCTGCCCGCCGACGCGAAGGTGGTCGGCTACGTCGGCCGGGTGGCGCACGAGAAGGGCTGGGCCCACTTCGTCGAGCTGGCCGCCCGGCTGGCCGCCGACCCGCCGGCGGAGCCCGTCGTGTTCCTCGTCGTCGGCGACGGGCCGCAGCGCCCGAGGATGGAGGAGCGGGTGGCCGCGGCCGGGCTCTCCGACCGGTTCGTGTTCACCGGGTTCCTGCCCAACCACGAGGTTCCGCTGACGATGAGCGGGATCGACGTCCTGGTGATGCCGTCGGTCCACGAGGAGCTGGGCGGCAGCGCGATCGAGGCGATGGTGCTGGGGGTCCCGGTGGTGGCCTACGGGGTCGGCGGGCTCCGGGACACCGTCGGCACGGTCGCGCCCGAGCTGCTGGTTCCGCCGCAGGACGTGCCGGCGCTGGTCCGCGCGGTCCGCGACGTACTCGCGCGGGGCGCGGAGCACCGGGCGCGGGTGCGCGCGGGCCGGCCGTGGCTGGAGGAGAACTTCGGCGACGGCGTCGGCGTCGACCGCACCGTGGCGCACTACCGGCGCGTCCTGGCCGGCCGAGGTGGTGGCGGCGACCTCGGCCCCGGCGTCCCGGGCCCCGGTGTCCCCAACCCCGGCGCCCTCAACCCGGGCGTCCCCGGACCCGGCGGCGCGGCCCCGGCGGACCCGCCCGACGGAGGCGCGTCCGCCGCCGGGCAGCGGCCGCCCGGCTCCGGTCCCTGA	MRLRVLRLTPFFHHDCVDRWPAEFDAVGGMQVQILRLSRQLARRGVRQEVLTVGFPGLPRVREDSPGLVVRITRAPMPRLRSELTGLVGLNLAWFLGAMAECARRRRSRRPDLIQVHADGQLWALLAGPIASALLRRPYSLVLHCSRLGVYQPMSRYDQWQHRFVAAVERWALRRADGVCALTARTADVVRAALRPHAVRVDVVPDSVDPEPPVDAGVPVAERLRAAGLPADAKVVGYVGRVAHEKGWAHFVELAARLAADPPAEPVVFLVVGDGPQRPRMEERVAAAGLSDRFVFTGFLPNHEVPLTMSGIDVLVMPSVHEELGGSAIEAMVLGVPVVAYGVGGLRDTVGTVAPELLVPPQDVPALVRAVRDVLARGAEHRARVRAGRPWLEENFGDGVGVDRTVAHYRRVLAGRGGGGDLGPGVPGPGVPNPGALNPGVPGPGGAAPADPPDGGASAAGQRPPGSGP	MKVMQLLPELNSGGVERGTLEIARALVAQGHQSLVVSNGGRLVSQLEAEGSTHLTLPIHKKSLSSLWQIRPLRQLIEEHQPDIVHVRSRVPAWLTHFALRKIPANKRPHLISTVHGFYSVNRYSAIMTQAEKVIAVSDSVVKYITGHYKNCPPQDIIRIYRGIDPAAFPHNYQPSAQWFNQVFNDFPELENKFLLCLPGRITRLKGHESLIELMQQLHSQYPQLHAVVVGGADVKKQAYLSELQNTIQSKGLADKITFVGHRSDIREWLAFSDIVLSLSNQAETFGRTALEALSVGTPVIGWNRGGVAEILSHVYPQGLVEAENEKALLEIVKHHIEQPQTVAPVTMFSLKDMCDQTLELYQSVLK	128.14	gnl|BL_ORD_ID|2781|hsp_num:0	3793			594	999	colistin A; colistin B; defensin
BGC0000692.1|Apramycin_12 # 10001 # 11140 # -1 # ID=1_12;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.722	BGC0000692.1|Apramycin_12 	10001	11140	-	Loose	900	26.5646	basS	31.43	3003583	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration; antibiotic efflux	pmr phosphoethanolamine transferase	ATGGGAGACGTCCGTTTCCCCTACCGGCTGGGCACGGCGTGCGTCGACCAGATCGTCGACCGGCTGGCCGAGCTGGAGGCCAGCCGGTACCTGGTGGTCGCCGACCCCACCGTCGCCGGCCTCTACGGCACCGACCTGGTGGAGCGCGTCCGCCGCACGGCCGGCCCCGCCGAGCTGCTCGTGCACGAGGGCGGTGAGGAGAACAAGGGGCTGGGCACCCTCGCGGAGCTGGTCGAGACCGCGTTGCGGCTGGGCGCCGACCGCCGCAGCATCGTCGTCGCGCTCGGCGGCGGGATCACCGGCAACATCGCCGGCCTCATGGCCGCGCTGATGTTCCGCGGCATCCGGCTGGTGCACGTGCCCACGACGATCGTCGCGATGCTGGACTCGGTCCTGTCGCTCAAGCAGGCGGTCAACAGCTCGGTCGGCAAGAACCTGGTCGGCACGTTCTACCAGCCGGTGGAGGTGCTCGCCGACACCGCTTTCCTGCGGACGCTGAGCACCAGGGACATCCGGTCGGGCCTGTGCGAGGTGGTCAAGAACGCCCTCGCGATCCGGCCGAGCATGATCGACCGGCTGGCCGCGCACCTGCCGCTGGACCAGCGCTACGACGACGACGTGATGCGCTGGATCATCGACGAGAGCATCGCGGCCAAGGCGCAGGTCACCGAGGCCGACGTCCACGAGCGGAAACAGGGCCTGGTCCTGGAGTACGGGCACACCGTGGGGCACGCCCTCGAACACGCCGCCAAGGGCGAGGTCTCGCACGGCGCCGCCGTGGGGCTGGGCATGCTCGCCGAGGCCGAGATCGCCCGCCGGCTCGGGCTGGCCGGCGAGGACCTCATCGAGCTGCACCGGGACCTCATCTCCCGGATGGGGATCGACCTGGCGTTCCCGGCCCACGTCAGCCCGGCCGACGTCCAGCTCCGCCTGCGCTACGACAACAAGCGCGGCTACCTCAGCGGAGCCGGCGACGACGGGTACGTGATGGTGCTGCTCAAGGCGCCGGGCGTCCCGCTCCAGTCGGAGGGCCTGCCGCTCACCGTCGCCGACCGGGCGGTCGTGGACGCGGTGGTCTCCGAGTTCGCCCACCCCGCGTCGGCGGCGGCGATCGGCCGTCGCACGCGGCCCGAGGGATAG	MGDVRFPYRLGTACVDQIVDRLAELEASRYLVVADPTVAGLYGTDLVERVRRTAGPAELLVHEGGEENKGLGTLAELVETALRLGADRRSIVVALGGGITGNIAGLMAALMFRGIRLVHVPTTIVAMLDSVLSLKQAVNSSVGKNLVGTFYQPVEVLADTAFLRTLSTRDIRSGLCEVVKNALAIRPSMIDRLAAHLPLDQRYDDDVMRWIIDESIAAKAQVTEADVHERKQGLVLEYGHTVGHALEHAAKGEVSHGAAVGLGMLAEAEIARRLGLAGEDLIELHRDLISRMGIDLAFPAHVSPADVQLRLRYDNKRGYLSGAGDDGYVMVLLKAPGVPLQSEGLPLTVADRAVVDAVVSEFAHPASAAAIGRRTRPEG	MSRAAVPSVRRRLLVNLLVGFVLCWLSVAALTYHLSLKQVNRLFDDDMVDFGEAALRLLDLATEDQAGEDGSITEIIERSREAIQGLPLLRRESALGYALWRDGQPLLSSLNLPPEITAQGPGFSTVEAQGTHWRVLQLNIDGFQIWISENLIYRQHTMNLLLFYSLFPLLLALPLLGGLVWFGVARGLAPLREVQAEVQQRSARHLQPIAVEAVPLEIRGLIDELNLLLERLRTALEAERRLTSDAAHEIRTPLASLRTHAQVALRSEDPKAHARGLLQVSRSVERISTLMEQILLLARLDGDALLEQFHPVNLATLAEDVLSELARQAIDKDIELSLHQETVHVMGIDLWLKAMVGNLVGNALRYTPAGGQVEIRVENRAQHAVLRVRDNGPGVALEEQQAIFTRFYRSPATSSGEGSGLGLPIVKRIVELHFGSIGLGKGLEGKGLEVQVFLPKTQPDATRPPARGPDSGRSHI	79.45	gnl|BL_ORD_ID|2350|hsp_num:0	249			936	1143	polymyxin B
BGC0000692.1|Apramycin_14 # 12575 # 13507 # -1 # ID=1_14;partial=00;start_type=GTG;rbs_motif=AGG;rbs_spacer=5bp;gc_cont=0.735	BGC0000692.1|Apramycin_14 	12575	13507	-	Loose	275	27.335	Streptomyces rimosus otr(A)	31.32	3002891	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic target protection	tetracycline-resistant ribosomal protection protein	GTGAAGATCGCCTACAACTCGCTGTGCGGCAGCGACCTGTCGCTGTACCGCGGGGTGTGGCACGGGTTCACCTACCCCGTCGTGCCGGGCCACGAGTGGAGCGGCACCGTCGTGGAGGTCAACGGGGCCGACGAGAGCCTGCGCGGCGCGAAGGTGACCGGCGACCTCACCGTCTCCTGCAGCCGGTGCGCCCCGTGCGAGCGCGGCACCCCGGTGCTCTGCGACAACCTCCAGGAGCTCGGGTTCAACCGGGACGGCGCGTGCGCGGAGTACATGACCATCCCCGTGCACAACGTGTACCGGCTGCCGGACGCGCTGGACCTGAAGGCGGCCTGCCAGGTCGAGCCGCTCGCGGTGGCCCTGCACGCGGTCGCCAACGCGGGGATCGGGGAGGGCGACAAGGTCGCGGTGCTGGGCGCGGGCGGCATCGGGCTGCTGCTGATGCAGGCCGCCGCGCTGCGCGGCGCGACGGTCACGACCGTCTCCGAGCCGGTGACCGAGCGGAGGGAGCGGGCGCGGGAGCTCGGCGCGCGGACCGTGACCTCGGCGGCGCCGGGTGAGTTGGCGGCGCTGGTGGAGAGCCGCCCGGAGCTGGTGCCGGACGTCGTGCTGGAGGCGTCGGGCTACCCCGTCGCGGTCCAGGAGGCGATCGAGGTCGTGCGCCCCGGCGGCCGGATCGGGCTCGTCGGCTACCGGGTCGAGGAGACCGGCGTGATGGCCCCGCACCACGCCACCGTCAAGGCGCTGTCGATCAGGGGCTCGCTCGGCCCCGGCGGCCGGTTCGCCGAGGCGATCGAGGTGCTGGCCTCGGGCGCGATCAACACCGACGCGCTGCTGAGCCACGAGTTCGGCCTCGACGACTACGCGGACGCCCTGGACCTCGCGCTGCGGCGCACGAACGGCAACACGCGCTCGTACTTCAACCTCGGCTGA	MKIAYNSLCGSDLSLYRGVWHGFTYPVVPGHEWSGTVVEVNGADESLRGAKVTGDLTVSCSRCAPCERGTPVLCDNLQELGFNRDGACAEYMTIPVHNVYRLPDALDLKAACQVEPLAVALHAVANAGIGEGDKVAVLGAGGIGLLLMQAAALRGATVTTVSEPVTERRERARELGARTVTSAAPGELAALVESRPELVPDVVLEASGYPVAVQEAIEVVRPGGRIGLVGYRVEETGVMAPHHATVKALSIRGSLGPGGRFAEAIEVLASGAINTDALLSHEFGLDDYADALDLALRRTNGNTRSYFNLG	MNKLNLGILAHVDAGKTSLTERLLHRTGVIDEVGSVDAGTTTTDSMELERQRGITIRSAVATFVLDDLKVNLIDTPGHSDFISEVERALGVLDGAVLVVSAVEGVQPQTRILMRTLRRLGIPTLVFVNKIDRGGARPDGVLREIRDRLTPAAVALSAVADAGTPRARAIALGPDTDPDFAVRVGELLADHDDAFLTAYLDEEHVLTEKEYAEELAAQTARGLVHPVYFGSALTGEGLDHLVHGIRELLPSVHASQDAPLRATVFKVDRGARGEAVAYLRLVSGTLGTRDSVTLHRVDHTGRVTEHAGRITALRVFEHGSATSETRATAGDIAQAWGLKDVRVGDRAGHLDGPPPRNFFAPPSLETVIRPERPEEAGRLHAALRMLDEQDPSIDLRQDEENAAGAVVRLYGEVQKEILGSTLAESFGVRVRFDPTRTVCIEKPVGTGEALIELDTRTHNYFWGAPWVCASDRPSPARAITFRLAVELGSLPLAFHKAIEETVHTTLRHGLYGWQVTDCAVTLTRTGVRSPVSAADDFRKANARLVLMDALGRAGTEVHEPVSSFELEVPAARLSPVLAKLAELGATPGVPTAEGDVFRLEGTMPTSLVHDFNQRVPGLTQGEGVFLAEHRGYRPAVGQPPVRPRPEGPNPLNRDEYILHVLKRV	46.76	gnl|BL_ORD_ID|4807|hsp_num:0	1273			408	942	oxytetracycline
BGC0000692.1|Apramycin_15 # 13696 # 14460 # -1 # ID=1_15;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.731	BGC0000692.1|Apramycin_15 	13696	14460	-	Loose	400	25.7942	ErmS	43.33	3001304	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic; streptogramin B antibiotic	antibiotic target alteration	Erm 23S ribosomal RNA methyltransferase	GTGCGGTACGACCGGCTGCTGCCCAGGGAGTTCGAGGCCCGGCTCGCGGCGGCTCCCGTCGCCTACGTGCCGGTCGGCTCCCTGGAGTGGCACAGCGCCCACATGCCCTACGGCGTCGACACCGACAAGGCGACCGCGATCTGCGAGCGCGCGGCGCGCCGGCACGGCGGCATCGTGCTGCCGGGCAGCCCCTGGGGCTTCATGCAGGGCAACTGGCGCGGCGCGACCCACCCCGGCCTGCGGGTCGAGACGATCTTCCAGCTCTACACCGACATCCTGCGCGGTCTGTCCACTGTGGGCTTCCGCGCGGCGGTGGTGGTGTCCGGGCACTGGACCACCAAGCAGACGATCCCCATCGCCTGCGCCCTGGAGCGGGTCAGGAACGAGACCGGGCTGCGCGGCATGGTCACCTTCGACGGCTCGGACGACGACTGCGGGTTCGACCCCGAGCTGCACCTGGACATGGACCACGCCGGCGCGTTGGAGACCTCCGTGTACGGGGCGTTGTTCCCGGAGAACGTGCACCTGGAGCGGCTGGACGAGCTGGATCTCTCCGACCTGCCCGGCAGGGAGTGCCACCTGACCCGCTCCGGCATCCAGGGCAGGGACCCGAGGGAGCACGCCGACTTCGAGCGCGGCCGCTGGCACGTCGACCAGGTTGTGGACCTGCTCGGCGCCGAGGCGCGACGCCTGCTCGCCGAGGCCGAGGCTGCGCCGGCCGAGGCGGTGCCAGGGGCCGAGTCGGCGCCCCCGGCCGGCGGTTGA	MRYDRLLPREFEARLAAAPVAYVPVGSLEWHSAHMPYGVDTDKATAICERAARRHGGIVLPGSPWGFMQGNWRGATHPGLRVETIFQLYTDILRGLSTVGFRAAVVVSGHWTTKQTIPIACALERVRNETGLRGMVTFDGSDDDCGFDPELHLDMDHAGALETSVYGALFPENVHLERLDELDLSDLPGRECHLTRSGIQGRDPREHADFERGRWHVDQVVDLLGAEARRLLAEAEAAPAEAVPGAESAPPAGG	MARAPRSPHPARSRETSRAHPPYGTRADRAPGRGRDRDRSPDSPGNTSSRDGGRSPDRARRELSQNFLARRAVAERVARLVRPAPGGLLLEVGAGRGVLTEALAPYCGRLVAHEIDPRLLPALRDRFGGPHHAHVRISGGDFLAAPVPREPFALAGNIPYSRTAGIVDWALRARTLTSATFVTQLEYARKRTGDYGRWSLLTVRTWPRHEWRLLGRVSRREFRPVPRVDSGILRIERRERPLLPSAALGDYHRMVELGFSGVGGSLYASLRRAHRAGPLDAAFRAARLDRSVVVAYVTPEQWLTVFRTLRPVRSRPAGR	79.62	gnl|BL_ORD_ID|671|hsp_num:0	727			0	90	lincomycin; tylosin; pristinamycin IC; carbomycin; niddamycin
BGC0000692.1|Apramycin_16 # 14511 # 15470 # -1 # ID=1_16;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.700	BGC0000692.1|Apramycin_16 	14511	15470	-	Loose	500	26.9498	OXA-616	15.38	3005837	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	ATGATCACCGGCGGGACCGGCTCCCTCGGTCGCGCCTTCATCCGCAACGCGCTCGACACCCTCGGCTGCGACTCGGTGGTCGTCTACTCCCGCGACGAGCTCAAGCAGCGCGAGCTGCGCGAGGCGTTCGACCACGACCGCCGCCTGGAGTGGGTCATCGGCGACGTCCGCGACCCGGACCGGCTGCGCCACGCCATGCGCGACGTCGAGCACGTGGTGCACGCCGCCGCGTTGAAGCAGGTCGACACCGCGGAACGCAACTGCATCGAGTACATCCGCACCAACGTGCTCGGCGCGCAGAACGTCATCGACGCCGCCGTCGAGACCGGGGTCTCGCGGGTCGTGGCGCTGTCCACGGACAAGGCGTCCAGCCCGGTCAACCTCTACGGCGCCACCAAGCTCTGCGCGGACAAGCTCTTCGTCGCCGCGAGCGAGTACGCGGGCCGGCGGGGGACCAGGTTCGGCGTCGTGCGGTACGGCAACGTGCTCGGCAGCCGCGGTTCGGTGATCCCGTTGTTCAAACAGCTCGCCGCCGCCGGAAAACCGATCACCATCACCGACAAGCGGATGACCCGGTTCTGGCTCAGCATCGAGGCCGCCGTCCGGTTCATCGTCGAGTCCTTCGACCAGATGTCCGGCGGGGAGATCTTCGTTCCGCGCATTCCGAGCATGCGCGTCATCGACCTGGCGGAGGCGATCGCGCCGCGCAGCCCGATCCACGAGGTGGGCATCCGGCCGGGCGAGAAGCTCCACGAGGAGATGATCTCCGAGTCGGACGCCCGGCGGACGGTCCGGCTGGGCGACCGCTACGTCGTGCGCTCGTCGCTGGCCGAGGAGGCGGACGTCCCCGCCGGCGGCACCCCGGTCCCCGACGGCTTCAGCTACACGTCGGACAAGAACGACGAGTGGCTCTCCGTCGCGGACCTGCGCGCCGAGTACGCCGGGGCGGTGAGCGCGTGA	MITGGTGSLGRAFIRNALDTLGCDSVVVYSRDELKQRELREAFDHDRRLEWVIGDVRDPDRLRHAMRDVEHVVHAAALKQVDTAERNCIEYIRTNVLGAQNVIDAAVETGVSRVVALSTDKASSPVNLYGATKLCADKLFVAASEYAGRRGTRFGVVRYGNVLGSRGSVIPLFKQLAAAGKPITITDKRMTRFWLSIEAAVRFIVESFDQMSGGEIFVPRIPSMRVIDLAEAIAPRSPIHEVGIRPGEKLHEEMISESDARRTVRLGDRYVVRSSLAEEADVPAGGTPVPDGFSYTSDKNDEWLSVADLRAEYAGAVSA	MRNFIVFIMFLNIAIGEDKILGNFFKDYNTSGTFIVFDGKNYASNDFKRAKKAFSPASTFKIFNALIALDNGVVRDTKEIFYHYKGEKVFLPSWKQDASLSSAIKRSQVPAFKELARKIGLKTMQESLNKLSYGNAKISKIDTFWLDNSLQISAKNQADLLFKLSQNSLPFSKKNQEEVKEIILFKEDKIQKIYVKTGFNDSINLAWIVGFVKTKNKILSFALNVDIKDIKNIKIREELLEKYLAIITN	128.11	gnl|BL_ORD_ID|3872|hsp_num:0	4942			543	699	cloxacillin; oxacillin; cefalotin
BGC0000692.1|Apramycin_17 # 15731 # 16714 # -1 # ID=1_17;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.782	BGC0000692.1|Apramycin_17 	15731	16714	-	Loose	450	27.7202	Escherichia coli fabI mutations conferring resistance to isoniazid and triclosan	23.27	3004045	protein variant model	M159T	n/a	disinfecting agents and antiseptics; isoniazid-like antibiotic	antibiotic target alteration	antibiotic resistant fabI	ATGCGGGCGCGCGTCGTTGTCCGCCGCGCGGAACCGCCGCGCCGCGGCGGCGCGTGCGGAAGAACCGCCCCGCGGGCGGGTGATCGGGATGGTGACCAGGTGCGGGAACGTGGTGAGAGCCGGCGGGGCGACCCCGACCGGTGGACCGGTCGCGGCGGCGGCCGGCGAGTGGGAACGGCGTGGCGGACCGGGGTGGCCCGGGTCCTCGCGCGCGCCGTCGACGTGGGCGGGTTCCGGGTGACGGCGGCGGGTCCCAGGCGCGTGCTGGTCACCGGCGCCAGCCGGGGCCTGGGTCTGCGTGCAGCGGAGGCGTTGGCCGACCGGGGGTGGTCGGTCGTCCTGGGCTGCCGCCGGGTCGGCGACGTCGGGCCGGTGCTCGCGAGAGCGCGTGGTCGGGGCGCGCCGGTGTCCGCCGTCGCGCTGGACGTGACGGACCCGGGCAGCGTCGCCGCCGCCGTCGCGGCGGTGGCCGAGCTCGGCGGGCCGCTGCACGCCCTGGTCAACAACGCCGGGGTGTTCCGGCACGAGGAGGAGGAGTTCCAGGACCTCCGGCCTGGGGACGCGCTCGACCTGCTGCTGACCAACGCCTGCGGCCCGCTGCTGGTGACCAGGGCGTTCCTGCCGCTGCTGCGCGCCGCCGGCGGCGCGGCCGTGGTGAACGTGACCAGCCGGGACGCCGACGAGGACACCTTCGACGGCCTGTTCACCGGCTACCGGATGGCCAAGGCCGCCCTGAACGCGATGACCAGGAACCTGGCCATCGCGCTGCGACCCGACCGGATCGTGGTCAACGCCGTCGACCCGGGGTGGATCCCCACCGACATGGGCGGACCGGAGGCACCGGACAGCCTGGACGCCGCGGTGGCGGCGGTGGCCGGCGCCGTCGAGCTGGCTGGCGGCGACCGGACCGGCCGCCTCCTGCGCGCCCAGCGCCCGCCCGGGTCCCCGGGGCGCCGCCGGGCTGACGGGGCGACGCGGCGCTGA	MRARVVVRRAEPPRRGGACGRTAPRAGDRDGDQVRERGESRRGDPDRWTGRGGGRRVGTAWRTGVARVLARAVDVGGFRVTAAGPRRVLVTGASRGLGLRAAEALADRGWSVVLGCRRVGDVGPVLARARGRGAPVSAVALDVTDPGSVAAAVAAVAELGGPLHALVNNAGVFRHEEEEFQDLRPGDALDLLLTNACGPLLVTRAFLPLLRAAGGAAVVNVTSRDADEDTFDGLFTGYRMAKAALNAMTRNLAIALRPDRIVVNAVDPGWIPTDMGGPEAPDSLDAAVAAVAGAVELAGGDRTGRLLRAQRPPGSPGRRRADGATRR	MGFLSGKRILVTGVASKLSIAYGIAQAMHREGAELAFTYQNDKLKGRVEEFAAQLGSDIVLQCDVAEDASIDTMFAELGKVWPKFDGFVHSIGFAPGDQLDGDYVNAVTREGFKIAHDISSYSFVAMAKACRSMLNPGSALLTLSYLGAERAIPNYNVMGLAKASLEANVRYMANAMGPEGVRVNAISAGPIRTLAASGIKDFRKMLAHCEAVTPIRRTVTIEDVGNSAAFLCSDLSAGISGEVVHVDGGFSIAAMNELELK	124.81	gnl|BL_ORD_ID|4712|hsp_num:0	2666			18	582	triclosan
BGC0000692.1|Apramycin_19 # 17684 # 19195 # 1 # ID=1_19;partial=00;start_type=GTG;rbs_motif=AGG;rbs_spacer=10bp;gc_cont=0.720	BGC0000692.1|Apramycin_19 	17684	19195	+	Loose	600	29.6462	Streptomyces venezuelae rox	46.88	3007209	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic inactivation	rifampin monooxygenase	GTGAAGTTCGTGACGCTGCAGGAGGCCGCAGGACAGGTCTTTGACGTCTGCGTCGTCGGGAGTGGCGCCTCCGGCGCGGTCACGGCGTTCACGCTGGCCGGGCGCGGCATGTCCGTGCTCGTCGTCGAGCAGGGCGACGTCATCCCGCCGGGCGGCAAGATCGACGATCACCTGGACCCGGACAGCTGGGCCTACGCCTGGCGGCACGGCCGCTGGTGGACCACCGGCTACCCGTGGTCCGCGCAGGCCTTCGGCGGCGGGACCGTCTTCTACGCCGGCGTGTCCTTCCGGTACCACCCGCGCGACTTCGCGCCCAGCCCCGAGTTCCTGGGCGCGGCAGCCTACGAGCACTGGGGTCTGACCCGGCAGGACCTGGACCCCTACTACGACTGGATCGAGGACCAGCTCGCCGTGGCCGGGCCGTCCGGGGCCACCGTCGCCGAGTACCAGTTCCCCCGCTACAAGCGGGAGAAGCTGAGCTACACCAGCCAGGGCCGCGTGCTGGCCGAGGCCGCCGCCCGGCTCGGCTGGCGGCCCGTGGCCACTCCCCTGGCCATCAGCGGCGTCGCCGACCGCTTCACCCGCGGCTGCCAGCAGCTCACGCCGTGCACCGACAACGCCTGCCCGGTCGGCGCGAAGGCGGACGTGGCCTCCCGGCTGCTGAGCCGCTGCGACGACAACCTGTCCGTCCTGTTGCGCACCAGGGTCGCGCGGCTGGTGGCCACGCGCCCCGGCGTGGTGGACTCGGCCGAGGTCCTGCACGCCGACGAGCGGGACAGCGGCACCATCCGGGCCCGCCGGTTCGTCCTGGCGGCCAACGCGATCCAGTCCGCCGCCCTGCTGCTGCGCTCCGCCTCGCGCCTGGAGCCGGACGGCATGGGCAACAGCAGCGGCATGGTCGGCCAGCACCTGGCCATGAAGAACAGCGTCTACCTCCGCACCCACGTCCGGCGCGAGGACGACTACCGGCCCCTGCAACACCGGTACTCCAGCATGACGTCGCTCGACTCGATGTACGACCCGGAGTTCCCCGACGGGATGGGCGGCCTGATCTACGAGGCCAACCCGTGGGACAACGTGAAGGACAACGCGTTCATGCCGCTCCAACTGGAGTGCAGCGTCGGCGACCGGCCGCGGGCCAGGAACCAGGTGCGGCTGAGCAAGGACCTCGACTCCTACGGCCTGCCGCGGGTGGTCATGGACTACGTCGCGCACAAGCGCGACCTGGCCCGCCTGCGCGTCCTGCGGGGGCGCGCGAGCGAGCTGCTGCGCTCGCTGGGCGGCCGGGTCAGGCACGTGAGCACCAAGTACGAGCTGGGCAGCGCCCACCTGCACGGAACCCTGCGCTCGGGGCGCGACCCCCGTTCCTCGGTGACGGACCCGCTGGGCCGCCTGCACGACTACGACAACGTCTGGGCGGTGGATGGCGCGGTCTTCCCCTTCGCCGGCAACCTCAATCCGACGCTCACCATCCAGGCCAACGCCCGGCGGATCGCCTCCGCCATCTCCTGA	MKFVTLQEAAGQVFDVCVVGSGASGAVTAFTLAGRGMSVLVVEQGDVIPPGGKIDDHLDPDSWAYAWRHGRWWTTGYPWSAQAFGGGTVFYAGVSFRYHPRDFAPSPEFLGAAAYEHWGLTRQDLDPYYDWIEDQLAVAGPSGATVAEYQFPRYKREKLSYTSQGRVLAEAAARLGWRPVATPLAISGVADRFTRGCQQLTPCTDNACPVGAKADVASRLLSRCDDNLSVLLRTRVARLVATRPGVVDSAEVLHADERDSGTIRARRFVLAANAIQSAALLLRSASRLEPDGMGNSSGMVGQHLAMKNSVYLRTHVRREDDYRPLQHRYSSMTSLDSMYDPEFPDGMGGLIYEANPWDNVKDNAFMPLQLECSVGDRPRARNQVRLSKDLDSYGLPRVVMDYVAHKRDLARLRVLRGRASELLRSLGGRVRHVSTKYELGSAHLHGTLRSGRDPRSSVTDPLGRLHDYDNVWAVDGAVFPFAGNLNPTLTIQANARRIASAIS	MFDVIVVGGGPTGLMLAGELRLHGVRVLVLEKETEPTRQSRAQGLHVRSIEVMAQRGLLERFLERGHTVAVGGFFAGLATSWPERLDTAHSYVLAVPQVITEQLLAEHATALGAEIRRGRALVGLRQDEDGVTVDLADGEQLRARYVVGCDGGRSTVRKLLGVAFPGEPSRVETLLGEMEMTASQEELTSVMTEVRKTQQRFGAMPLGDGVFRVVVPAEGVAEDRTASPTLDEFKQQLRAHAGTDFGVHSPRWLSRFGDATRQAERYRVDRVFLAGDAAHIHPPTGGQGLNLGIQDAFNLGWKLAAEVDGWAPEGLLDTYHAERHPVATEVLDNTRAQIQLMSTEPGPQAVRRLMAELVEFENVNRYLIEKITAISVRYDVGEGHELLGRRMRDLALKHGRLYERMHEGRGLLLDQTGRLSVAGWEDRVDHVVEVSEELDVPAVLLRPDGHVVWAGEDQQELLTRMPAWFGAATAG	105.67	gnl|BL_ORD_ID|4833|hsp_num:0	5820			0	96	rifampin; rifaximin; rifapentine
BGC0000692.1|Apramycin_20 # 19265 # 20626 # 1 # ID=1_20;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=8bp;gc_cont=0.706	BGC0000692.1|Apramycin_20 	19265	20626	+	Loose	700	26.5646	adeS	36.0	3000549	protein homolog model	n/a	n/a	glycylcycline; tetracycline antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGCGGCTCGGCAAGTTACTGCTGGTGAGTCCGAAGACCTCCTTCGGACGTGATCTGCAACGGACCTACGCCGGAGGGCTCGGCACCGTCTGCAAGGACGAGGACTTCCTGCTGCCCCCGCTCGACCTGATGCGGCTGGCCGGCGTCCTGCGGGAGGACGCCGACGAGATCGCGATCGCGGACGAGGAGGTCACCGGCGTCGTCGCCGCCTCCCCCGGCAGCACGGTGATCTGCCACGTCTCCCTGCCCAGCCTGCTGGAGGACGCCGAGCGCATGGCGACCTTCCGGGAGCAGGGCGCGCGCTGCTACGCCTACACGAGCATCCGCAGCCCCGTGCAGTGGCGGGAGCTGTTCGAGCGGGCCGGCTGCGTCGGCATCCTGCTGCCCGAGTCGATCTCGTTCGCCCGCGCCGCGCTCGCCGGCGACGCCACCGTCCCCGGCCTGGTCACCCCGGAGAACCTGCTGGAGCCGCGGCACCACCAGCCGCGGTTCGGCGACCTGGCGGCCGAGCCGCTGCCCGCGCGGGACCTCGTCGACCACACGCCCTACATGTTCCCGCCGATCTCCCTCAACGGGATCACGAGCATCAACGGCAGCTTCGGCTGCCCCTACCCGTGCCGCTTCTACTGCCCGTACCCGCTCAGCGAGGGCCGCAAGATCCGCACCTACCCGGTGGAGCGGATCGTCGCCGAGTTCCGCCAGTGCGCCGAGCTGGGCATCACCGCCGCGGTCTTCCGCGACCCGGTGTTCTCCTTCCACCGCGACCGCACGATCGAGATGTGCCGGGCGATCGAGGCCGCCGGCACCGGGGTGCCGTGGTGGTGCGAGACCCGCATCGACCGGCTCGACGAGGAGGTCGTCGCCGCGCTCGTGGCCGCCGGCTGCGTCGGCGTCGAGGTGGGCGTGGAGAGCGGCGACCCGGAGATGCAGGCGACGGCCGTGCGCAAGCGGCTCGACCTGGACACCGTCCGCCGGTTCCACGCGGTGGCCAGGAAGGCCGGGCTGAAGCTGGTCTTCCTGTTCCTGATCGGCCTGCCCAGGGAGACCAGGATGTCGATCCGGCGCACGTTCGACTTCATCCTCGAACTCGGACTGGCGCACACCGAGTTCAACCTCAGCGTGATCACGCCGTACCCGGGAACCGAGCTGCACCAGATCGCCGTGGACAAGGGCTGGATCGACGGCTCGCAGGACAACTTCACCAGCCACAACGCGGTCATGCACACGGACCAGCTCACGATCGGGGACCTGGAGCAGGCCAGCCGGTTCGTCGACGAGCTGCACGGGGTGTGCAAGGCGGGGCCCGCGGAGCGGGCCGAGTTCCAGGCCAGGCTGCACGCCTGGTCGACCAGCGACGCCTGA	MRLGKLLLVSPKTSFGRDLQRTYAGGLGTVCKDEDFLLPPLDLMRLAGVLREDADEIAIADEEVTGVVAASPGSTVICHVSLPSLLEDAERMATFREQGARCYAYTSIRSPVQWRELFERAGCVGILLPESISFARAALAGDATVPGLVTPENLLEPRHHQPRFGDLAAEPLPARDLVDHTPYMFPPISLNGITSINGSFGCPYPCRFYCPYPLSEGRKIRTYPVERIVAEFRQCAELGITAAVFRDPVFSFHRDRTIEMCRAIEAAGTGVPWWCETRIDRLDEEVVAALVAAGCVGVEVGVESGDPEMQATAVRKRLDLDTVRRFHAVARKAGLKLVFLFLIGLPRETRMSIRRTFDFILELGLAHTEFNLSVITPYPGTELHQIAVDKGWIDGSQDNFTSHNAVMHTDQLTIGDLEQASRFVDELHGVCKAGPAERAEFQARLHAWSTSDA	MKSKLGISKQLFIALTIVNLSVTLFSIVLGYIIYNYAIEKGWISLSSFQQEDWTSFHFVDWIWLATVIFCGCIISLVIGMRLAKRFIVPINFLVEAAKKISHGDLSARAYDNRIHSAEMSELLYNFNDMAQKLEVSVKNAQVWNAAIAHELRTPITILQGRLQGIIDGVFKPDEVLFKSLLNQVEGLSHLVEDLRTLSLVENQQLRLNYELFDLKAVVEKVLKAFEDRLDQAKLVPELDLTSTPVYCDRRRIEQVLIALIDNAIRYSNAGKLKISSEVVADNWILKIEDEGPGIATEFRDDLFKPFFRLEESRNKEFGGTGLGLAVVHAIIVALKGTIKYSNQGSKSVFTIKISMGHEEMG	125.48	gnl|BL_ORD_ID|166|hsp_num:0	183			27	177	tigecycline; tetracycline
BGC0000692.1|Apramycin_21 # 20651 # 22051 # 1 # ID=1_21;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=10bp;gc_cont=0.737	BGC0000692.1|Apramycin_21 	20651	22051	+	Loose	500	25.7942	AIM-1	30.95	3000853	protein homolog model	n/a	n/a	cephalosporin; cephamycin; penam	antibiotic inactivation	AIM beta-lactamase	ATGTCGCCGCACCCGCAGAAGCGAAGATCCCGCACCAGCGCGCTCCTCGCGGTCGCCGCCCTCGCGGCGGCGCTCTCCCCGACGATCCCCGCCGTGGCCGACGACACCGCCGAGGGCTTCGCCCTGGCCCCCAACGCGGACCGGACGCACCACGTCCGGAGCGCGGTCAGGGGCGGCAAGGCCCGCAACGTCCTGCTGTTCGTCGGCGACGGCATGGGCGACTCCGAGATCACCCTGGCCCGCAACTACGAGCTGGGGGCCGCCGGCCGGCTGAACCTGGACCGGCTGCCCCTGACCGGCGCCTACACCACCTACTCGGTCGCCAAGGGCGACCCGGGGCGCGTCGAGTACGTCACCGACTCGGCGGCGGCGGCCACGGGCTACGCCATCGGGGCCAAGACCTACAACGGCGCCGTGGGCGTCGACGCGCACGGCAGGGAGCGGCCGACGATCCTGGAGCTGGCCAAGCGCCGGGGCTACCGCACCGGCAACGTCACCACCGCCGAGCTCCAGGACGCCACCCCCGCCGCCCTCTCGGCGCACGTGCTCGACCGCACCTGCCGAGGCCCGCAGGACATGAAGGAGTGCGCGCCGAACGACAAGCGGAACGGCGGCGCGGGCTCGATCGCCGAGCAGCAGGTCGCGCTGCGGGCCGACGTGCTCATGGGCGGTGGCGGCAAGTACTTCGACCAGCAGGTCGCCGCCGGCCAGTTCGCCGGGCGGACCGTGCGCCAGCAGGCGGTCGACTCCGGCTTCCAGGTGATCACCTCGGCCGACCAGATGCGGGCCCTCGACCGGGAGCGGCCCGTACTCGGCGTGTTCGCCGCCGAGGGTCTGGACAGCACCTGGACCGGCCCGCCGGCCAAGGCGGGCGGGACGCCGCCGAGCCGGTGCGCGGAGAACCCCGCCCGCCGGAAGGACCAGCCGACGCTGGCCGACATGACCCGTGCCTCGATCGACCTGCTCGAACGCCGATCCCGCGGCCACGACAGGGGGTTCTTCCTCCAGGTCGAGGGCGCGCAGATCGACTGGGGCGCGCACGACGGCCTGCCCTGCGAGCAGATCGGCGAGACCGTCCAGTTCGACCGGGCGGTGGCCGTCGGCATGGAGTTCGCGCGGCGGCGCCCGGACACGCTGGTCATCGTCACCGCCGACCACGCGCAGACCACCCAGATCATCCCCAACGGCCAGAAGAGCCCCGGCATGACCGCCACCCTCATCACCAACGAGGGCGGCCACATGACGGTCAACTACGCCACCGGGCTGCCCGGCGAGCTCCAGGAGCACACCGGGACCCAGGTGCGGATCGCCGGGTACGGGCCCCAGGCCGCCAACGTCGTCGGCGTCACCGACCAGACCGACCTGTTCCGCACCCTGTCCAGGGCGATGGGAGTCCGCTGA	MSPHPQKRRSRTSALLAVAALAAALSPTIPAVADDTAEGFALAPNADRTHHVRSAVRGGKARNVLLFVGDGMGDSEITLARNYELGAAGRLNLDRLPLTGAYTTYSVAKGDPGRVEYVTDSAAAATGYAIGAKTYNGAVGVDAHGRERPTILELAKRRGYRTGNVTTAELQDATPAALSAHVLDRTCRGPQDMKECAPNDKRNGGAGSIAEQQVALRADVLMGGGGKYFDQQVAAGQFAGRTVRQQAVDSGFQVITSADQMRALDRERPVLGVFAAEGLDSTWTGPPAKAGGTPPSRCAENPARRKDQPTLADMTRASIDLLERRSRGHDRGFFLQVEGAQIDWGAHDGLPCEQIGETVQFDRAVAVGMEFARRRPDTLVIVTADHAQTTQIIPNGQKSPGMTATLITNEGGHMTVNYATGLPGELQEHTGTQVRIAGYGPQAANVVGVTDQTDLFRTLSRAMGVR	MKRRFTLLGSVVALALSSTALASDAPASRGCADDAGWNDPAMPLKVYGNTWYVGTCGISALLVTSDAGHILVDAATPQAGPQILANIRALGFRPEDVRAIVFSHEHFDHAGSLAELQKATGAPVYARAPAIDTLKRGLPDRTDPQFEVAEPVAPVANIVTLADDGVVSVGPLALTAVASPGHTPGGTSWTWRSCEGDDCRQMVYADSLTAISDDVFRYSDDAAHPGYLAAFRNTLARVAALDCDILVTPHPSASGLWNRIGPRAAAPLMDTTACRRYAQGARQRLEKRLAEEAATSPSSGARP	153.80	gnl|BL_ORD_ID|652|hsp_num:0	707			168	285	
BGC0000692.1|Apramycin_22 # 22165 # 23289 # 1 # ID=1_22;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=3bp;gc_cont=0.742	BGC0000692.1|Apramycin_22 	22165	23289	+	Loose	100	30.4166	FosA8	38.78	3007371	protein homolog model	n/a	n/a	phosphonic acid antibiotic	antibiotic inactivation	fosfomycin thiol transferase	ATGATGAGCAGCCACGTCTCTTTCGCCCACGTGGACACGGAGAACGCCGCTCTCGTCGACGAGTTCCTGCCGGTGCTCAAGGAGCGGCTCGCCGGCGGGGTGTTCATCGGAGGGGAGGAGGTCGACCGGCTGGAGCGCCGGATCGCCCGCCTCCACCAGGTCGAGCACGCGGTCGCGGTCAACTCCGGCACCGACGCGCTCCGGCTCACCTTCCGCGCGTTGGGGATTCCCCGCGGCACCACCGGGATCACCGTCGCGAACACCTTCGTCGCCACGGTCGGCGCCCTGCTGTCGGAGGGGATCAACCCCCTGCTCGTCGACGTCGGCGCCGACGAGAACGTCGACGTGGCGGCGCTGGAGGAGGCGATCACCCCGGACACCAGCGTGGTCGTCGCCGTGCACCTGCGCGGCCTGCCCGCCGAGATCGCGGCGGTCCGGGAGATCTGCGCGCGCCGCGGCGTCCACCTCGTCGAGGACTGCGCGCAGGCGGTGCTGGCCTCCGCCGGCGGCGTCCCGGTCGGCGCGTTCGGCGTCGCCGGGTGCTTCAGCCTGCACCCGCTGAAGAACCTCGGCGCCTGCGGCGACGCCGGCGTGGTCGTGACCAACGACGACGCGCTGGCCGCCGAGCTGCGGTTGCTGCGCAACCACGGCCTGCGGGACCGGGACACCGTGGTCCGCTGGGGCGAGAACTCCCGGCTGGACGCCCTCCAGGCGAGCCTGCTCAACGTCAAGCTCGACCACCTGGAGGAGTGGACCCGACGGCGGCGGGACCTCGCCGCCCGCTACGACGAGCTCCTGGCCGACCTCCCCCTGGTCCTGCCGCCCCGCCCCGAGGACCGCGTGCACGTGTACCACCGGTACTCCGTCATGACCGAGCACCGGGACGCCCTCCGGGCCCACCTGGCCGACGCGGGCGTCCAGACCGCCGTGCACTACCCCATCCCGATCCACCGGCAGCCCGCCGCCCGCGGCGGCCAGCTCCGGATCGCCGGACGCGGGCTGGCCGTGACCGAGCGGCAGGCCGGCCAGATCCTCTCGCTCCCGCTGCACCCCCTCATGCCGGAGCGCGACCTGCGCGCCACCGCGCGGGAGGTCCGGGCCTTCTTCGAGAGCCGGCCCCGGTAG	MMSSHVSFAHVDTENAALVDEFLPVLKERLAGGVFIGGEEVDRLERRIARLHQVEHAVAVNSGTDALRLTFRALGIPRGTTGITVANTFVATVGALLSEGINPLLVDVGADENVDVAALEEAITPDTSVVVAVHLRGLPAEIAAVREICARRGVHLVEDCAQAVLASAGGVPVGAFGVAGCFSLHPLKNLGACGDAGVVVTNDDALAAELRLLRNHGLRDRDTVVRWGENSRLDALQASLLNVKLDHLEEWTRRRRDLAARYDELLADLPLVLPPRPEDRVHVYHRYSVMTEHRDALRAHLADAGVQTAVHYPIPIHRQPAARGGQLRIAGRGLAVTERQAGQILSLPLHPLMPERDLRATAREVRAFFESRPR	MLNALNHLTLAVSNLPASITFWRDLLGLRLHAEWHTGAYLTCGDLWLCLSYDETRTFIPPQNSDYTHYAFSVEPEHFDAVAQKLKDAGVTVWKENKSEGASFYFLDPDGHKLELHVGDLAARLAACREKPYAGMVFTSDEA	265.25	gnl|BL_ORD_ID|4906|hsp_num:0	5899			138	267	fosfomycin
BGC0000692.1|Apramycin_23 # 23342 # 24379 # 1 # ID=1_23;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.697	BGC0000692.1|Apramycin_23 	23342	24379	+	Loose	1200	71.2478	arnA	29.23	3002985	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	pmr phosphoethanolamine transferase	ATGAACAAGCACGCCGGTCCCGGCCTCGTCCTGATCACGGGCGGCGCCGGCTACATCGGCTCGGTCCTCACCCGGCGGCTGCTGGACAAGCGGGTCCGGGTGCGGGTGCTCGACTCGCGGATCTTCGGCGACGGCCTGCGGGACCTCGCCGACCCCGGCCTGGAGAACGTCCAGGGCGACATCCGCGACGCCGACCTGTTCCGGACGGCACTGCGGGACGTCGACGTCGTCGTCCACCTCGCGGCCGTGGCCAACGACCCCAGCTTCGACCTGAACCCCGAGCTGGGCCGCTCGGTGAACTTCGAGTGCCTCGACCACGTCATGCGGCTCTCGAAGGAGGCCGGCGTCCGCCGCTTCGTCTACGCCTCCTCGGCCAGCGTCTACGGGATCAGCGACTCCCCCGAGGTCGACGAGTCCCACCCGCTGGTGCCGATCACCGACTACAACCGGTACAAGGCACTGGGCGAGGAAATCCTCTTCCCCCTCACCGACACCTCGTTCGAGACCGTCGCGCTCCGCGCGGCGACCGTGTGCGGCGTGTCCACCCGCCAGCGCCTCGACCTCACGGTCAACCTGCTGACCGCCCAGGCCGTGGGCAACCGCGAGATCACCGTCTTCGGCGGCGCCCAGTACCGCCCCAACGTCCACATCGACGACCTGGTCGAGGTCTACCAACGACTGGTCCTGGACGACTCGCTGGGCGCCCTCAACGGCGCCCCCATCAACGTCGGCAACGAGAACCTCCCGGTCGCCGACATCGCGAAGGTCATCGCCACCAGGGTCACCGCCAAACTCGGCGCCGAGGTCACCACCACGACCACCCCCACCGACGACCGCCGCTCCTACCGCCTGACCTCCCGCCGCCTCCACCAGCTCCTGGGCATCACCCCCACCCGCACCGTCGCCGACGCCAGCGACGACGTCACCGACGCCATCCTCGACGGCCGCCTCCCCAACCCCCTCACGGAAGCCCGTTACTACAACGTCCGCTGGATGAAAGACCCCCGCAGCCAGGACCTCCTCACCTACACCCCCTGA	MNKHAGPGLVLITGGAGYIGSVLTRRLLDKRVRVRVLDSRIFGDGLRDLADPGLENVQGDIRDADLFRTALRDVDVVVHLAAVANDPSFDLNPELGRSVNFECLDHVMRLSKEAGVRRFVYASSASVYGISDSPEVDESHPLVPITDYNRYKALGEEILFPLTDTSFETVALRAATVCGVSTRQRLDLTVNLLTAQAVGNREITVFGGAQYRPNVHIDDLVEVYQRLVLDDSLGALNGAPINVGNENLPVADIAKVIATRVTAKLGAEVTTTTTPTDDRRSYRLTSRRLHQLLGITPTRTVADASDDVTDAILDGRLPNPLTEARYYNVRWMKDPRSQDLLTYTP	MTSKAVVFAYHDIGCTGIEALLNAGYEIAAVFTHADDPRENTFYASVARLCAERGIPLHAPEDVNHPLWLERIRQLRPDFLFSFYYRRLLGAELLACAARGAYNLHGSLLPRYRGRAPANWVLVNGETQTGVTLHRMIERADAGPILAQQAVAIDPEDTALSLHGKLRKAAGALLRDSLPLLALGVLPEVEQDESQASHFGRRTPADGLLDWHRPARQLYDLVRAVTQPYPGAFCQVGEQKLIVWSAEVVAGNHGREPGSVLSCDPLRIACGEDSLVLRFGQRGERGLYLAGTQLATELGLVEGARLRGAACSPQRRTRVLILGVNGFIGNHLSERLLRDGRYEVHGMDIGSDAIERLKADPHFHFVEGDIGIHSEWLEYHVKKCDVILPLVAIATPIEYTRNPLRVFELDFEENLRIVRYCVKYGKRVVFPSTSEVYGMCQDPDFDEDRSNLVVGPINKQRWIYSVSKQLLDRVIWAYGQQGLRFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILHLVEGTPIRLVDGGAQKRCFTDVDDGIEALARIIDNRDGRCDGQIVNIGNPDNEASIRQLGEELLRQFEAHPLRAQFPPFAGFREVESRSFYGDGYQDVAHRKPSIDNARRLLDWQPTIELRETIGKTLDFFLHEALREREAQA	52.11	gnl|BL_ORD_ID|1513|hsp_num:0	1643			957	1704	polymyxin B
BGC0000692.1|Apramycin_26 # 26677 # 27489 # -1 # ID=1_26;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=4bp;gc_cont=0.701	BGC0000692.1|Apramycin_26 	26677	27489	-	Loose	700	28.4906	FOX-8	27.94	3002161	protein homolog model	n/a	n/a	cephalosporin; cephamycin	antibiotic inactivation	FOX beta-lactamase	ATGCTGGACGTGGGCGGCGCCGAACGGACCGCGCGGAAGCGGAAGCAGACCACGCAGGCGGCGAGGGCGGTGGCCGCGGCACGCGGCGGCAACGACCGCCGCAACGTCATCATCGGCGTGGTCATCGTGGTGGTGATGGCCGTCGCCGTGATCGGCGGCGTGCTCTACACCCGGAACAGCAGCACCTCCGGCGGGGCCGGGGACATCCCGGTGACCGCCGCGCACGCGCAGTACCCCACCAAGGTGGAGGACGACGGCACGGTGCTGGCCGGCAACGAGTCGGCCAAGGTCACCGTGGACGTCTACGAGGACTTCCTGTGCCCGGCCTGCGGCTCGTTCGAGAAGCTCTACGGCGAGCAGCTGGAGAAGGCCGTCGCCGACGGCAAGGTCAAGGCGCGCTACCACATCCTCAACCTGCTCGACCGGTACTCGAACCCGGCCGGCTACTCGCTGGAGGCGGCCAACGCGGCGATCGCGGCGGCCGGCACCGGCAAGTTCCCCGACTTCCACGCCAGCCTGTTCCGCACCCAGCCCAAGGAGGGTGGGAAGGGCTACACCCAGGACCAGCTCGTCAAGCTGGGGCAGGCGGTCGGCATCTCCGGCGGCGACTTCGAGTCGGCCGTGCGGGGCGGCAAGTACAACGAGCAGATCAAGAAGCAGCTGGAGGCCGCCGGCAACAACCCGGCCCTCCAGCGGGAGAGCGCGCAGGGCAAGAGCTTCGGCACCCCGACCATCGCCGTGAACGGCACGATGGTCGACCTGCAGGACGCCGAGTGGCTGAAGAAGGCGATCGAGCAGTCCGGCCAGGGCTGA	MLDVGGAERTARKRKQTTQAARAVAAARGGNDRRNVIIGVVIVVVMAVAVIGGVLYTRNSSTSGGAGDIPVTAAHAQYPTKVEDDGTVLAGNESAKVTVDVYEDFLCPACGSFEKLYGEQLEKAVADGKVKARYHILNLLDRYSNPAGYSLEAANAAIAAAGTGKFPDFHASLFRTQPKEGGKGYTQDQLVKLGQAVGISGGDFESAVRGGKYNEQIKKQLEAAGNNPALQRESAQGKSFGTPTIAVNGTMVDLQDAEWLKKAIEQSGQG	MQQRRAFALLTLGSLLLAPCTYASGEAPLTATVDGIIQPMLKEYRIPGIAVAVLKDGKAHYFNYGVANRESGQRVSEQTLFEIGSVSKTLTATLGAYAAVKGGFVLDDKVSQHAPWLKGSALDGVTMAELATYSAGGLPLQFPDKVDSNDKMQTYYRSWSPVYPAGTHRQYSNPSIGLFGHLAANSLGQPFEQLMSQTLLPKLGLHHTYIQVPESAMANYAYGYSKEDKPIRVTPGVLAAEAYGIKTGSADLLKFAEANMGYQGDALVKSAIALTHTGFYSVGEMTQGLGWESYDYPVTEQVLLAGNSPAVSLQANPVTRFAVPKAMGEQRLYNKTGSTGGFGAYVAFVPARGIAIVMLANRNYPIEARVKAAHAILSQLAE	70.68	gnl|BL_ORD_ID|1027|hsp_num:0	1123			768	972	
BGC0000692.1|Apramycin_28 # 28268 # 28969 # 1 # ID=1_28;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.745	BGC0000692.1|Apramycin_28 	28268	28969	+	Loose	880	25.0238	arlS	31.71	3000839	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; disinfecting agents and antiseptics	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	GTGGGCCACGGGGAAATCGGGCACATCCACTCCGACGTCTCCGGGGGCTGGCTGCGGCCGGCGGTCTTCGGCGCGATGGACGGCCTGGTCACCAACATCGCGCTGGTGGCCGGCGTCGGGGGCGGCGGGGCCGGACCCGACGTGGTCGTGCTGTCCGGGGTGGCCGGCCTGGTCGCCGGAGCCCTCTCGATGGCGATCGGCGAGTACACGTCGGTGGAGACCCAGAACGACGCGGTGCGCGCCGAGGTCGCGGTGGAACGGGCGGAACTGCGCGACAACCCCGAAGGGGAGCGGGCCGAACTGGTCGAGGCGTACGTCGCGATGGGGCTGACCCGGCCGACGGCCGAGCGCGTGGCCGCCGAGGTCCACGCGAACCCGGAGCTCGCGGTGCGGGTTCACGTCACCCAGGAGCTGGGCGTCAATCCGGACGAACAGCCCTCGCCGTGGACGGCCGCCCTCCTGTCCTTCCTCTGCTTCTCCCTCGGCGCGCTGACCCCGCTGGCGCCGTTCCTCCTCGGGTTCGCCTCGCTGCCGGCCGGCCTGCTCGTCGGCGGCGCGGGGCTGTTCGTCGCCGGCGCCCTGGTCGCGCGGTGGACGACTCGTTCGTGGTGGCGCAACGGCCTGCGGCAGCTCGCCCTCGGCGCGCTCGCGGCGGTCGCCACCTTCCTCGTCGGCTCGGTCGTCGGCGTCGTCACGACCTGA	MGHGEIGHIHSDVSGGWLRPAVFGAMDGLVTNIALVAGVGGGGAGPDVVVLSGVAGLVAGALSMAIGEYTSVETQNDAVRAEVAVERAELRDNPEGERAELVEAYVAMGLTRPTAERVAAEVHANPELAVRVHVTQELGVNPDEQPSPWTAALLSFLCFSLGALTPLAPFLLGFASLPAGLLVGGAGLFVAGALVARWTTRSWWRNGLRQLALGALAAVATFLVGSVVGVVTT	MTKRKLRNNWIIVTTMITFVTIFLFCLIIIFFLKDTLHNSELDDAERSSSDINNLFHSKPVKDISALDLNASLGNFQEIIIYDEHNNKLFETSNDNTVRVEPGYEHRYFDRVIKKRYKGIEYLIIKEPITTQDFKGYSLLIHSLENYDNIVKSLYIIALAFGVIATIITATISYVFSTQITKPLVSLSNKMIEIRRDGFQNKLQLNTNYEEIDNLANTFNEMMSQIEESFNQQRQFVEDASHELRTPLQIIQGHLNLIQRWGKKDPAVLEESLNISIEEMNRIIKLVEELLELTKGDVNDISSEAQTVHINDEIRSRIHSLKQLHPDYQFDTDLTSKNLEIKMKPHQFEQLFLIFIDNAIKYDVKNKKIKVKTRLKNKQKIIEITDHGIGIPEEDQDFIFDRFYRVDKSRSRSQGGNGLGLSIAQKIIQLNGGSIKIKSEINKGTTFKIIF	51.66	gnl|BL_ORD_ID|165|hsp_num:0	182			870	987	ciprofloxacin; acriflavine; norfloxacin
BGC0000692.1|Apramycin_29 # 29198 # 29896 # 1 # ID=1_29;partial=01;start_type=ATG;rbs_motif=AGG;rbs_spacer=4bp;gc_cont=0.758	BGC0000692.1|Apramycin_29 	29198	29896	+	Loose	575	24.6386	SPR-1	30.91	3006996	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	SPR beta-lactamase	ATGTCCGCACGCACCAGACTGCGGGGTCGAACACTCGGCGTCGCCGCCACCCTCGCGGCGCTGGCCGCCGTCGCGCTCACCGGCGCGGCCGGCTCCGCGGTCGCCGCGCCCGCCGAGCAGCTCTCCGGCGGCCAGCTCGCCGCCGTGGACTACCTGAGCGGCCGGGGCCTCGACCGGGCCGAGGCGGTGCGCCGGGTGCTCGCCCAGGAGGGGCAGACCCGCACCGCGACCCAGCTCGCCGACAAGCTCGGCGCGCGGGTGGCCGGCTCCTACGTCGACCAGGGATCGGGCGCCCTGGTCGTCAACGTCACCGACGACGGCGCGGCCGACGAGGTGCGCCGCTCCGGCGCGACGGCGAAGAAGGTCGACCGCGGCGTCACGGACCTCAACGCGGCCAAGGCCAGGCTCGACCAGGCCGGCAAGGCCGCGCGGGGCGCGAGCTGGTACGTCGACGTGCCGAACAACCAGGTCGTGGTCCAGGCTCCCGCCGGCGACAGCTCGGCCGGCGTGACCGACCTGCTGCGCACGGCGGAGGCGCTGGGCGGCACGGCCCGCGTGGAGCGCGTCCAGGGCAAGGCCACCACCCAGGCCACCAACCTCTACGGCGGCCAGCAGATCGAGTTCAGCGTCAACGGCAGCGGCTACGTGTGCTCGGACGGCTTCAACGCCACCGACCGCTCCGGCCGGGCCGTGATGATC	MSARTRLRGRTLGVAATLAALAAVALTGAAGSAVAAPAEQLSGGQLAAVDYLSGRGLDRAEAVRRVLAQEGQTRTATQLADKLGARVAGSYVDQGSGALVVNVTDDGAADEVRRSGATAKKVDRGVTDLNAAKARLDQAGKAARGASWYVDVPNNQVVVQAPAGDSSAGVTDLLRTAEALGGTARVERVQGKATTQATNLYGGQQIEFSVNGSGYVCSDGFNATDRSGRAVMI	MKKNLGYLTAMTVALCFGAQAQLNPAQPLSSAPPYSLFEQWAQPVAPFQMFPHVYYVGTRNLSSVLLSTPEGLILIDAALDASAPAIRAHIEALGFNIKDLRYILNSHARLDQAGGIARLQVWSGAKVVASAANAQQLALGGKQDFALGDALSFPPVKVDIIVGEGDSITLGDLKLTALMTPGHLPGATSWLTTLHQGGQSYRLVYADSLATPDYYLIDNKNYPSLVQDIRGSFARLAQQQADIFIVNKGTRFDLDNKMQRLQAGDLDAFVDRQGLQQYVQQSQQTFEAQLKQQQSKM	78.19	gnl|BL_ORD_ID|4591|hsp_num:0	5661			213	369	
BGC0000692.1|Apramycin_27 # 27495 # 28037 # -1 # ID=1_27;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.748	BGC0000692.1|Apramycin_27 	27495	28037	-	Loose	1400	23.8682	Mycobacterium tuberculosis katG mutations conferring resistance to isoniazid	37.93	3003392	protein variant model	S303L	n/a	isoniazid-like antibiotic	antibiotic target alteration	isoniazid resistant katG	ATGGCTGTCGGAATGCCCGCCCGCCGGTCGGTCGGGGACCTGCTCGGCACGCTGGTCCGGTTCGGACTGGCCGCGGTCTGGCTCGTCTCCGGCGCGATCAAGGCCGCGGCCCCGGAGCGGACCTACCTGTCCGTGCAGGCGTTCCGGGTGCTGCCGGACGCCCTGGCCGGGCCGGTGGCGGCCGTGCTGCCGTTCGTCGAGCTGGGACTCGGCGTCCTGGTGCTGTTCGGCGTGGGCACGCGCGTCGTCGCGGCGTTGTCCTGCCTGGTGCTGCTCGCGTTCGTCGCCGGCATCACGCAGGCGTGGGCACGGGGGCTGAGCATCGACTGCGGGTGCTTCGGCGGCGGCGGCGACGTCGCCCCCGGCGAGACCCGCTACCCCGAGGAACTGGCCAGGGACACCGGTTTCCTGGCGCTGGCCGTCTGGCTGCTCGTCCGGCCGCGCTCGCTGCTGTCCGTCGACGGCTGGCTGGGCCTGGGCCGTCCGGCGCGCGACGGGGATGATGGTGACGACCGGGACGAACCCGTCCCGGCCGAGTCGTAG	MAVGMPARRSVGDLLGTLVRFGLAAVWLVSGAIKAAAPERTYLSVQAFRVLPDALAGPVAAVLPFVELGLGVLVLFGVGTRVVAALSCLVLLAFVAGITQAWARGLSIDCGCFGGGGDVAPGETRYPEELARDTGFLALAVWLLVRPRSLLSVDGWLGLGRPARDGDDGDDRDEPVPAES	MPEQHPPITETTTGAASNGCPVVGHMKYPVEGGGNQDWWPNRLNLKVLHQNPAVADPMGAAFDYAAEVATIDVDALTRDIEEVMTTSQPWWPADYGHYGPLFIRMAWHAAGTYRIHDGRGGAGGGMQRFAPLNSWPDNASLDKARRLLWPVKKKYGKKLSWADLIVFAGNCALESMGFKTFGFGFGRVDQWEPDEVYWGKEATWLGDERYSGKRDLENPLAAVQMGLIYVNPEGPNGNPDPMAAAVDIRETFRRMAMNDVETAALIVGGHTFGKTHGAGPADLVGPEPEAAPLEQMGLGWKSSYGTGTGKDAITSGIEVVWTNTPTKWDNSFLEILYGYEWELTKSPAGAWQYTAKDGAGAGTIPDPFGGPGRSPTMLATDLSLRVDPIYERITRRWLEHPEELADEFAKAWYKLIHRDMGPVARYLGPLVPKQTLLWQDPVPAVSHDLVGEAEIASLKSQIRASGLTVSQLVSTAWAAASSFRGSDKRGGANGGRIRLQPQVGWEVNDPDGDLRKVIRTLEEIQESFNSAAPGNIKVSFADLVVLGGCAAIEKAAKAAGHNITVPFTPGRTDASQEQTDVESFAVLEPKADGFRNYLGKGNPLPAEYMLLDKANLLTLSAPEMTVLVGGLRVLGANYKRLPLGVFTEASESLTNDFFVNLLDMGITWEPSPADDGTYQGKDGSGKVKWTGSRVDLVFGSNSELRALVEVYGADDAQPKFVQDFVAAWDKVMNLDRFDVR	24.32	gnl|BL_ORD_ID|1955|hsp_num:0	1176			837	924	isoniazid
